Watch Out Sanofi! Chinese Fast-Follower Emerges With Dupixent Rival

Promising Top-Line Data

 
• By Dexter Jie Yan
  
fast followers
Keymed's stapokibart is closing in on Dupixent in the atopic dermatitis space in China • Source: Shutterstock

More from China

More from Focus On Asia